全文获取类型
收费全文 | 4572篇 |
免费 | 333篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 137篇 |
妇产科学 | 220篇 |
基础医学 | 555篇 |
口腔科学 | 34篇 |
临床医学 | 755篇 |
内科学 | 677篇 |
皮肤病学 | 101篇 |
神经病学 | 358篇 |
特种医学 | 73篇 |
外科学 | 384篇 |
综合类 | 73篇 |
一般理论 | 10篇 |
预防医学 | 663篇 |
眼科学 | 36篇 |
药学 | 414篇 |
中国医学 | 4篇 |
肿瘤学 | 386篇 |
出版年
2023年 | 19篇 |
2022年 | 35篇 |
2021年 | 77篇 |
2020年 | 45篇 |
2019年 | 92篇 |
2018年 | 108篇 |
2017年 | 84篇 |
2016年 | 117篇 |
2015年 | 115篇 |
2014年 | 149篇 |
2013年 | 246篇 |
2012年 | 376篇 |
2011年 | 384篇 |
2010年 | 229篇 |
2009年 | 189篇 |
2008年 | 355篇 |
2007年 | 331篇 |
2006年 | 319篇 |
2005年 | 299篇 |
2004年 | 303篇 |
2003年 | 262篇 |
2002年 | 237篇 |
2001年 | 63篇 |
2000年 | 32篇 |
1999年 | 38篇 |
1998年 | 41篇 |
1997年 | 42篇 |
1996年 | 43篇 |
1995年 | 40篇 |
1994年 | 19篇 |
1993年 | 32篇 |
1992年 | 20篇 |
1991年 | 17篇 |
1990年 | 10篇 |
1989年 | 10篇 |
1988年 | 8篇 |
1987年 | 10篇 |
1986年 | 7篇 |
1985年 | 15篇 |
1984年 | 14篇 |
1983年 | 11篇 |
1982年 | 9篇 |
1981年 | 12篇 |
1980年 | 5篇 |
1979年 | 7篇 |
1978年 | 7篇 |
1976年 | 6篇 |
1974年 | 5篇 |
1973年 | 3篇 |
1972年 | 5篇 |
排序方式: 共有4915条查询结果,搜索用时 15 毫秒
41.
Hitoshi Ishida Akira Nozawa Haruo Nukaya Lesley Rhodes Paul McNabb Patrick T Holland Kuniro Tsuji 《Toxicon》2004,43(6):701-712
We examined metabolism of PbTxs in New Zealand cockle, Austrovenus (A.) stutchburyi, and greenshell mussel, Perna (P.) canaliculus, by means of liquid chromatography coupled with tandem mass spectrometry. PbTx-2, PbTx-3 and BTX-B5 were detected in Karenia (K.) brevis culture medium in the ratio of ca. 50:2:5. The amounts of PbTx-3 and BTX-B5 were greatly increased in both seawater and shellfish exposed to K. brevis cultures or supernatant prepared by disruption of K. brevis under appropriate condition, while those of PbTx-2 were decreased. Some PbTx-2 was present in P. canaliculus, but not in A. stutchburyi. Low levels of BTX-B1 were detected in A. stutchburyi, but not P. canaliculus. Levels of PbTx-3 and BTX-B5 were highest immediately after exposure and then declined rapidly in both shellfish. BTX-B1 increased in concentration after exposure, and was then gradually eliminated from A. stutchburyi. Three successive exposures of A. stutchburyi to K. brevis cultures resulted in similar initial levels of PbTx-3 and BTX-B5, while BTX-B1 accumulated after each dose. In P. canaliculus, initial levels of PbTx-3 were similar, while PbTx-2 and BTX-B5 accumulated after each dose. PbTx-3 and BTX-B5 are proposed to be suitable markers for monitoring shellfish toxicity after a red tide event. 相似文献
42.
Ezetimibe/simvastatin (Inegy, Vytorin) therapy combines two lipid-lowering compounds with complementary mechanisms of action, thereby blocking the two sources of plasma cholesterol and improving lipid profiles. Thus, intestinal absorption of dietary cholesterol and related phytosterols is blocked by ezetimibe, with the biosynthesis of cholesterol in the liver inhibited by simvastatin.Developing management trends for primary hypercholesterolemia include the aggressive reduction of low-density lipoprotein cholesterol (LDL-C) to goals lower than previously considered appropriate, the targeting of lipid subfractions and atherogenic indices other than LDL-C alone, and the broader use of combination lipid-lowering therapy. In line with these trends, ezetimibe/simvastatin is an effective and generally well tolerated adjunct to dietary therapy for markedly reducing LDL-C levels, providing a 52% reduction with the recommended starting dosage. Furthermore, ezetimibe/simvastatin is formulated with variable doses of simvastatin (i.e. 10/10 mg, 10/20 mg, 10/40 mg, and 10/80 mg) and hence, the dosage may be adjusted to suit the individual patient's needs. As longer-term efficacy, tolerability, economic and outcome data accrue, ezetimibe/simvastatin will be positioned more definitively relative to existing and emerging lipid-lowering treatments. Currently, ezetimibe/simvastatin therapy represents a valuable novel option for the management of primary hypercholesterolemia across diverse patient populations and as an adjunct to other lipid-lowering treatments in those with homozygous familial hypercholesterolemia. 相似文献
43.
44.
Michael Lowe Lesley Murray Alok Tyagi George Gorrie Sarah Miller Krishna Dani the NHS Greater Glasgow Clyde Headache Service 《The journal of headache and pain》2022,23(1)
BackgroundCalcitonin gene-related peptide (CGRP) inhibitors have been developed as options for treatment of chronic and episodic migraine. We present our experience of the use of erenumab in a tertiary headache centre.MethodsThis was a prospective clinical audit of all patients commenced on erenumab following a locally agreed pathway and criteria over a consecutive period. Patients received monthly erenumab 140 mg for 3 months. Data were collected prospectively at baseline and 3 months follow up.ResultsOne hundred three patients were commenced on erenumab during the study period. Patients had tried a median of 7 previous prophylactics, including onabotulinum toxin A in 94%. At 3 months there was a reduction in median total (28 to 20, 29% reduction, p < 0.0001) and severe (15 to 5, 67% reduction, p < 0.0001) headache days. 39.8% of patients achieved at least a 30% reduction in total headache days; 61.8% of patients achieved at least a 50% reduction in severe headache days. Meeting either of these thresholds was considered a positive response, 68% of patients achieved this. Presence of daily headache pattern was negatively associated with response, (56% response vs. 90% without daily headache, p = 0.0003). There was no association between age, gender, presence of medication overuse or number of previously tried prophylactic treatments and response to erenumab. 43% of patients reported at least one adverse effect, most commonly constipation (26%); treatment was discontinued in 3 patients due to adverse effects.ConclusionsErenumab was an effective treatment for chronic migraine in this treatment resistant population over 3 months of follow up. Presence of daily headache predicted poorer response but there was still a significant positive response rate in this group. 相似文献
45.
Sefonias Getachew Adamu Addissie Edom Seife Tariku Wakuma Susanne Unverzagt Ahmedin Jemal Lesley Taylor Andreas Wienke Eva J Kantelhardt 《The oncologist》2022,27(8):e650
IntroductionMany women in rural Ethiopia do not receive adjuvant therapy following breast cancer surgery despite the majority being diagnosed with estrogen-receptor-positive breast cancer and tamoxifen being available in the country. We aimed to compare a breast nurse intervention to improve adherence to tamoxifen therapy for breast cancer patients.Methods and MaterialsThe 8 hospitals were randomized to intervention and control sites. Between February 2018 and December 2019, patients with breast cancer were recruited after their initial surgery. The primary outcome of the study was adherence to tamoxifen therapy by evaluating 12-month medication-refill data with medication possession ratio (MPR) and using a simplified medication adherence scale (SMAQ) in a subjective assessment.ResultsA total of 162 patients were recruited (87 intervention and 75 control). Trained nurses delivered education and provided literacy material, gave additional empathetic counselling, phone call reminders, and monitoring of medication refill at the intervention hospitals. Adherence according to MPR at 12 months was high in both the intervention (90%) and control sites (79.3%) (P = .302). The SMAQ revealed that adherence at intervention sites was 70% compared with 44.8% in the control sites (P = .036) at 12 months. Persistence to therapy was found to be 91.2% in the intervention and 77.8% in the control sites during the one-year period (P = .010).ConclusionBreast nurses can improve cost-effective endocrine therapy adherence at peripheral hospitals in low-resource settings. We recommend such task sharing to overcome the shortage of oncologists and distances to central cancer centers. 相似文献
46.
Barclay L 《Midwifery》2008,24(1):13-21
OBJECTIVE: to describe and analyse birthing models in a number of countries, particularly Samoa and China, that have been the focus of my recent research; to discuss how cultural frameworks, colonisation and ideas of what is 'modern' influence the nature, place of birth and its attendant. IMPLICATIONS FOR PRACTICE: midwives need to reflect on their practice and consider broader health policy and how it affects health systems. They also need to understand the social, economic, historical and cultural context of practice, including the influence of gender inequality and attitudes to women and themselves as midwives. 相似文献
47.
48.
Rennan Garcias Moreira Julia Maria SaraivaDuarte Alexandre Costa Pereira Martha SosaMacias Carlos GalavizHernandez Meddly Lesley Santolalla Wagner C. S. Magalhes Camila Zolini Thiago Peixoto Leal Zsolt Balzs Adrin Llerena Robert H. Gilman Jos Geraldo Mill Victor Borda Heinner Guio Timothy D. OConnor Eduardo TarazonaSantos Fernanda RodriguesSoares 《CTS Clinical and Translational Science》2022,15(6):1400
49.
Dubrow R Silverberg MJ Park LS Crothers K Justice AC 《Current opinion in oncology》2012,24(5):506-516
PURPOSE OF REVIEW: Combination antiretroviral therapy (ART) has turned HIV infection into a complex chronic disease. This article documents cancer risk among HIV-infected persons, reviews immune system effects of HIV infection in relation to cancer risk, discusses implications for cancer prevention, and suggests future research directions. RECENT FINDINGS: There has been a shift in the cancer spectrum from AIDS-defining cancers (ADC) to non-ADC, although the burden of ADC remains high. Although a high prevalence of non-HIV cancer risk factors among HIV-infected persons contributes to cancer risk, substantial evidence has accumulated in favor of an independent association between HIV-induced immunodeficiency and elevated risk of many specific cancer types, most of viral cause, although further work is needed to disentangle immunodeficiency and smoking effects for lung cancer, and immunodeficiency and hepatitis virus effects for liver cancer. Relationships between cancer risk and two other immune system hallmarks of HIV infection, chronic inflammation, and immune dysfunction/senescence, remain poorly understood. SUMMARY: Early, sustained ART is a crucial component of cancer prevention. Continued epidemiologic monitoring is needed to detect possible effects on cancer risk of specific ART classes or medications, long-term exposure to systemic inflammation or immune dysfunction, or earlier or more effective ART. 相似文献
50.